Modified Bacterial Cellulose for Biomedical Applications. 2022

Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
Institute of Materials Research and Engineering, Agency for Science, Technology and Research (A*STAR), 2 Fusionopolis Way, Singapore, 138634, Singapore.

Bacterial cellulose, or microbial cellulose, had gained tremendous interest as a hydrogel material for biomedical purposes in the recent years. It has many intrinsic physiological properties like fibrous nature, ultrafine 3D nanostructure network, high water holding capacity, excellent mechanical properties, biocompatibility and biodegradability that allow for the use of such purposes, and the lacking properties can be easily supplemented or enhanced by modifications. In this review, some of the biomedical applications that uses bacterial cellulose are discussed. These include wound healing, drug delivery, tissue engineering and tumor cell and cancer therapy. In each section, different modifications of BC are showcased and examined on how they benefit the application. Finally, key takeaways on these modifications are also deliberated.

UI MeSH Term Description Entries
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide
D020100 Hydrogels Water swollen, rigid, 3-dimensional network of cross-linked, hydrophilic macromolecules, 20-95% water. They are used in paints, printing inks, foodstuffs, pharmaceuticals, and cosmetics. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrogel,In Situ Hydrogel,In Situ Hydrogels,Patterned Hydrogel,Patterned Hydrogels,Hydrogel, In Situ,Hydrogel, Patterned
D023822 Tissue Engineering Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures. Engineering, Tissue

Related Publications

Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
December 2021, Biotechnology advances,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
June 2009, Acta biomaterialia,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
August 2012, Carbohydrate polymers,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
January 2022, International journal of molecular sciences,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
November 2017, International journal of biological macromolecules,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
August 2008, Journal of biomedical materials research. Part B, Applied biomaterials,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
January 2021, Current medicinal chemistry,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
January 2019, Current pharmaceutical design,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
January 2020, Current pharmaceutical design,
Karen Yuanting Tang, and Jerry Zhi Xiong Heng, and Casandra Hui Teng Chai, and Chui Yu Chan, and Beverly Qian Ling Low, and Serene Ming En Chong, and Hong Yi Loh, and Zibiao Li, and Enyi Ye, and Xian Jun Loh
September 2019, Nanomaterials (Basel, Switzerland),
Copied contents to your clipboard!